Intra-Cellular Therapies
ITCI
#1813
Rank
โ‚ฌ8.64 B
Marketcap
81,54ย โ‚ฌ
Share price
-0.22%
Change (1 day)
52.11%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.17 Billion

According to Intra-Cellular Therapies's latest financial reports the company's total liabilities are โ‚ฌ0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intra-Cellular Therapies - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.12 B34.55%
2022-12-31โ‚ฌ92.02 M44.68%
2021-12-31โ‚ฌ63.6 M29.41%
2020-12-31โ‚ฌ49.14 M-1.99%
2019-12-31โ‚ฌ50.14 M45.27%
2018-12-31โ‚ฌ34.52 M142.94%
2017-12-31โ‚ฌ14.2 M11.53%
2016-12-31โ‚ฌ12.74 M77.22%
2015-12-31โ‚ฌ7.18 M-17.18%
2014-12-31โ‚ฌ8.68 M75.41%
2013-12-31โ‚ฌ4.94 M130.52%
2013-03-31โ‚ฌ0.02 M
2012-12-31โ‚ฌ2.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ2.86 M-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.77 M-71.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.25 B 46.27%๐Ÿ‡บ๐Ÿ‡ธ USA